Klaus Rabe
- The race for healthy lungs starts with spirometry testingBy Monica Fletcher and Klaus RabeMonica Fletcher1Education for Health, Warwick, UKKlaus Rabe2Dept of Internal Medicine, Christian Albrechts University, Kiel and Dept of Pulmonary Medicine and Medical Director, Grosshansdorf Clinic, Grosshansdorf, Germany
- Efficacy of roflumilast in the frequent exacerbation COPD phenotypeBy Jadwiga Wedzicha, Klaus Rabe, Peter Calverley, Fernando Martinez, Dirk Bredenbröker, Manja Brose and Udo-Michael GoehringJadwiga Wedzicha1Academic Unit of Respiratory Medicine, UCL Medical School, London, United KingdomKlaus Rabe2Center for Pulmonology and Thoracic Surgery, Krankenhaus Grosshansdorf, Grosshansdorf, GermanyPeter Calverley3School of Clinical Sciences, University Hospital Aintree, Liverpool, United KingdomFernando Martinez4Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, United StatesDirk Bredenbröker5Department of Respiratory Medicine, Nycomed GmbH, Konstanz, GermanyManja Brose6Department of Data Science, Nycomed GmbH, Konstanz, GermanyUdo-Michael Goehring5Department of Respiratory Medicine, Nycomed GmbH, Konstanz, Germany
- Granzyme B expression in lung of fatal asthmaticsBy Yvonne Nussbaumer-Ochsner, Luiz Silva, Annemarie van Schadewijk, Marisa Dolhnikoff, Thais Mauad, Klaus Rabe and Pieter HiemstraYvonne Nussbaumer-Ochsner1Pulmonology, Leiden University Medical Center, Leiden, NetherlandsLuiz Silva2Pathology, University of Sao Paulo School of Medicine, Sao Paulo, BrazilAnnemarie van Schadewijk1Pulmonology, Leiden University Medical Center, Leiden, NetherlandsMarisa Dolhnikoff2Pathology, University of Sao Paulo School of Medicine, Sao Paulo, BrazilThais Mauad2Pathology, University of Sao Paulo School of Medicine, Sao Paulo, BrazilKlaus Rabe1Pulmonology, Leiden University Medical Center, Leiden, NetherlandsPieter Hiemstra1Pulmonology, Leiden University Medical Center, Leiden, Netherlands
- Onset of action and effect of withdrawal of roflumilast in COPDBy Klaus Rabe, Thomas Similowski, Dirk Bredenbröker, Peter Teichmann and György Böszörményi-NagyKlaus Rabe1Center for Pulmonology and Thoracic Surgery, Krankenhaus Grosshansdorf, Grosshansdorf, GermanyThomas Similowski2Service de Pneumologie et de Reanimation, Groupe Hospitalier Pitie-Salpetriere, Paris, FranceDirk Bredenbröker3Dept. of Respiratory Medicine, Nycomed GmbH, Konstanz, GermanyPeter Teichmann4Dept. of Medical Scientific Strategy, Nycomed GmbH, Konstanz, GermanyGyörgy Böszörményi-Nagy5Dept. of Pulmonology, National Korányi Institute of Pulmonology, Budapest, Hungary
- Effects of roflumilast in highly symptomatic COPD patientsBy Leonardo Fabbri, Udo-Michael Goehring, Manja Brose and Klaus RabeLeonardo Fabbri1Department of Respiratory Medicine, University of Modena & Reggio Emilia, Modena, ItalyUdo-Michael Goehring1Department of Respiratory Medicine, University of Modena & Reggio Emilia, Modena, ItalyManja Brose1Department of Respiratory Medicine, University of Modena & Reggio Emilia, Modena, ItalyKlaus Rabe1Department of Respiratory Medicine, University of Modena & Reggio Emilia, Modena, Italy
- MAdL: A new diagnostic marker for adenocarcinomasBy Holger Schultz, Sebastian Marwitz, Bettina Baron-Luehr, Gernot Zissel, Christian Kugler, Klaus Rabe, Peter Zabel, Ekkehard Vollmer, Johannes Gerdes and Torsten GoldmannHolger Schultz1Clin.& Exp. Pathology, Research Center, Borstel, GermanySebastian Marwitz1Clin.& Exp. Pathology, Research Center, Borstel, GermanyBettina Baron-Luehr2Tumorbiology, Research Center, Borstel, GermanyGernot Zissel3Pneumology, University of Freiburg, GermanyChristian Kugler3Pneumology, University of Freiburg, GermanyKlaus Rabe3Pneumology, University of Freiburg, GermanyPeter Zabel3Pneumology, University of Freiburg, GermanyEkkehard Vollmer1Clin.& Exp. Pathology, Research Center, Borstel, GermanyJohannes Gerdes2Tumorbiology, Research Center, Borstel, GermanyTorsten Goldmann1Clin.& Exp. Pathology, Research Center, Borstel, Germany
- Prevalence and under-diagnosis of airflow limitation and other lung function abnormalities in patients with ischaemic heart disease: an interim analysis of the ALICE studyBy Joan Soriano, Nicolas Roche, John Cockcroft, Klaus Rabe, Mark Kearney, Guy Brusselle, Frits Franssen, Francisco Garcia Rio, Bo Lundbäck, Helen Marsden, Hana Muellerova, Paul Bloomfield, Gilbert Nadeau, Mathieu Vasselle, Zoe Adams, Angus Henderson and Leo FabbriJoan Soriano1Fundación Caubet-CIMERA Illes Balears, CIMERA, Bunyola, SpainNicolas Roche3Respiratory and Intensive Care Medicine, Hôtel-Dieu Hospital, University Paris Descartes, Paris, FranceJohn Cockcroft4Wales Heart Research Institute, Cardiff University School of Medicine, Cardiff, United KingdomKlaus Rabe9Department of Medicine, University Kiel, GermanyMark Kearney7Multidisciplinary Cardiovascular Research Centre, University of Leeds Medical School, United KingdomGuy Brusselle5Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumFrits Franssen2Program Development Centre, CIRO, Horn, NetherlandsFrancisco Garcia Rio11Hospital La Paz, IdiPAZ, Madrid, SpainBo Lundbäck8Dept of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, SwedenHelen Marsden10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomHana Muellerova10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomPaul Bloomfield10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomGilbert Nadeau10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomMathieu Vasselle12Excellence Medicale, GSK France, Marly Le Roi, FranceZoe Adams10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomAngus Henderson10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomLeo Fabbri6Department of Oncology Haematology and Respiratory Diseases, Section of Respiratory Diseases, University of Modena & Reggio Emilia, Modena, Italy
- Elastic fibers and fibronectin expression in severe asthmaticsBy Diogenes Ferreira, Raquel Annoni, Regina Maria Carvalho-Pinto, Klaus Rabe, Alberto Cukier, Rafael Stelmach, Marisa Dolhnikoff and Thais MauadDiogenes Ferreira1Pathology, University of São Paulo Medical School, São Paulo, BrazilRaquel Annoni1Pathology, University of São Paulo Medical School, São Paulo, BrazilRegina Maria Carvalho-Pinto2Pulmonary Department, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, BrazilKlaus Rabe3Zentrum Für Pneumologie Und Thoraxchirurgie, Krankenhaus Grosshansdorf, Grosshansdorf, GermanyAlberto Cukier2Pulmonary Department, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, BrazilRafael Stelmach2Pulmonary Department, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, BrazilMarisa Dolhnikoff1Pathology, University of São Paulo Medical School, São Paulo, BrazilThais Mauad1Pathology, University of São Paulo Medical School, São Paulo, Brazil
- Cardiac events among patients with CV comorbidities: Pooled analysis of COPD trials comparing tiotropium with salmeterolBy Kai-Michael Beeh, Klaus Rabe, Thomas Glaab, Diego Wyszynski, Inge Leimer, Norbert Metzdorf, Claus Vogelmeier and Leonardo FabbriKai-Michael Beeh1Department of Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, Wiesbaden, GermanyKlaus Rabe2Pneumologie, Krankenhaus Großhansdorf, Großhansdorf, GermanyThomas Glaab3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyDiego Wyszynski4Pharmaco Vigilance, Boehringer Ingelheim Limited, Bracknell, United KingdomInge Leimer3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyNorbert Metzdorf3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyClaus Vogelmeier5Internal Medicine, Hospital of the University of Marburg, Philipps-Universtat Marburg, Marburg, GermanyLeonardo Fabbri6Department of Medical and Surgical Specialties, University of Modena & Reggio Emilia, Modena, Italy
- Comparison of cardiovascular safety in a pooled analysis of COPD trials comparing tiotropium with salmeterolBy Claus Vogelmeier, Leonardo Fabbri, Thomas Glaab, Diego Wyszynski, Inge Leimer, Norbert Metzdorf, Kai-Michael Beeh and Klaus RabeClaus Vogelmeier1Department of Internal Medicine, Division for Pulmonary Disease, Hospital of the University of Marburg, Philipps-Universtat Marburg, Marburg, GermanyLeonardo Fabbri2Department of Medical and Surgical Specialties, University of Modena & Reggio Emilia, Modena, ItalyThomas Glaab3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyDiego Wyszynski4Pharmaco Vigilance, Boehringer Ingelheim Limited, Bracknell, United KingdomInge Leimer3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyNorbert Metzdorf3Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyKai-Michael Beeh5Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, Wiesbaden, GermanyKlaus Rabe6Pneumologie, Krankenhaus Großhansdorf, Großhansdorf, Germany
- Endosonography vs. conventional bronchoscopy for the diagnosis of sarcoidosis: A randomized controlled trialBy Martin von Bartheld, Artur Szlubowski, Felix Herth, Thais Mauad, Klaus Rabe and Jouke AnnemaMartin von Bartheld1Pulmonology, Leiden University Medical Center, Leiden, Zuid-Holland, NetherlandsArtur Szlubowski2Endoscopy Unit, Endoscopy Unit, John Paul II Hospital / Pulmonary Hospital Zakopane, Krakow / Zakopane, PolandFelix Herth3Pneumonology, Thoraxclinic, Heidelberg, GermanyThais Mauad4Pathology, University of Sao Paulo, Sao Paulo, BrazilKlaus Rabe5Pneumonology, Hospital Grosshansdorf, Grosshansdorf, GermanyJouke Annema1Pulmonology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands6Pulmonology, Academical Medical Center, Amsterdam, Netherlands
- An extensive function evaluation in severe asthma with airflow limitationBy Rodrigo Athanazio, Regina Carvalho-Pinto, Samia Rached, Frederico Fernandes, Klaus Rabe, Alberto Cukier and Rafael StelmachRodrigo Athanazio1Pulmonary Division, Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, BrazilRegina Carvalho-Pinto1Pulmonary Division, Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, BrazilSamia Rached1Pulmonary Division, Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, BrazilFrederico Fernandes1Pulmonary Division, Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, BrazilKlaus Rabe2Pulmonology, Center for Pulmonology and Thoracic Surgery, Grosshansdorf, GermanyAlberto Cukier1Pulmonary Division, Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, BrazilRafael Stelmach1Pulmonary Division, Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
- Remodeling of bronchial and pulmonary muscular arteries in mild/moderate COPDBy Raquel Annoni, Tatiana Lancas, Luiz Fernando Silva, Andreina Bruno, Salvatore Battaglia, Marisa Dolhnikoff, Pieter Hiemstra, Peter Sterk, Klaus Rabe and Thais MauadRaquel Annoni1Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, BrazilTatiana Lancas1Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, BrazilLuiz Fernando Silva1Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, BrazilAndreina Bruno2Institute of BioMedicine and Molecular Imm, Consiglio Nazionale delle Ricerche, Palermo, ItalySalvatore Battaglia3Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, ItalyMarisa Dolhnikoff1Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, BrazilPieter Hiemstra4Department of Pulmonology, Leiden University Medical Center, Leiden, NetherlandsPeter Sterk5Department of Respiratory Medicine, University of Amsterdam, Amsterdam, NetherlandsKlaus Rabe6Center for Pneumology and Thoracic Surgery, Grosshansdorf Hospital, Grosshansdorf, GermanyThais Mauad1Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil
- LATE-BREAKING ABSTRACT: PT003, a novel co-suspension MDI glycopyrronium/formoterol fixed-dose combination is superior to monocomponents in patients with COPDBy Klaus Rabe, Fernando Martinez, Roberto Rodriguez-Roisin, Leonardo M. Fabbri, Gary T. Ferguson, Paul Jones, Stephen Rennard, Michael Golden, Patrick Darken, Chad Orevillo, Tracy Fischer and Colin ReisnerKlaus Rabe1Lungen Clinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, GermanyFernando Martinez2Department of Internal Medicine, Weill Cornell Medical College, New York, NY United StatesRoberto Rodriguez-Roisin3Servei de Pneumologia, Institut del Tòrax, Hospital Clinic-IDIBAPS-CIBERES, Barcelona, SpainLeonardo M. Fabbri4Department of Oncology, Haematology and Respiratory Diseases, University of Modena, Modena, ItalyGary T. Ferguson5COPD, Pulmonary Research Institute of Southeast Michigan, Livonia, MI United StatesPaul Jones6Institute for Infection and Immunity, St. George's, University of London, London, United KingdomStephen Rennard7Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE United StatesMichael Golden8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesPatrick Darken8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesChad Orevillo8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesTracy Fischer8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesColin Reisner8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United States
- Versican and collagen-III expression in bronchial and pulmonary muscular arteries in COPD patientsBy Raquel Annoni, Ligia Couceiro, Silvio Barbosa, Tatiana Lancas, Salvatore Battaglia, Marisa Dolhnikoff, Pieter Hiemstra, Peter Sterk, Klaus Rabe and Thais MauadRaquel Annoni1Pathology, University of Sao Paulo, Sao Paulo, BrazilLigia Couceiro1Pathology, University of Sao Paulo, Sao Paulo, BrazilSilvio Barbosa1Pathology, University of Sao Paulo, Sao Paulo, BrazilTatiana Lancas1Pathology, University of Sao Paulo, Sao Paulo, BrazilSalvatore Battaglia2Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, ItalyMarisa Dolhnikoff1Pathology, University of Sao Paulo, Sao Paulo, BrazilPieter Hiemstra3Pulmonology, Leiden University Medical Center, Leiden, NetherlandsPeter Sterk4Respiratory Medicine, Academic Medical Centre -University of Amsterdam, Amsterdam, NetherlandsKlaus Rabe5LungenClinic Grosshansdorf, German Center for Lung Research, Grosshansdorf, GermanyThais Mauad1Pathology, University of Sao Paulo, Sao Paulo, Brazil
- The role of sustained physical inactivity in the progression of exercise intolerance and muscle depletion in COPDBy Benjamin Waschki, Anne Kirsten, Olaf Holz, Kai-Christian Müller, Miriam Schaper, Anna-Lena Sack, Thorsten Meyer, Klaus Rabe, Helgo Magnussen and Henrik WatzBenjamin Waschki1Pulmonary Research Institute, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, Germany2Pneumology, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, GermanyAnne Kirsten1Pulmonary Research Institute, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, GermanyOlaf Holz3Fraunhofer Institute for Toxicology and Experimental Medicine, BREATH, Member of the German Center for Lung Research, Fraunhofer Institute, Hannover, GermanyKai-Christian Müller2Pneumology, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, GermanyMiriam Schaper1Pulmonary Research Institute, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, GermanyAnna-Lena Sack1Pulmonary Research Institute, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, GermanyThorsten Meyer4Institute for Epidemiology, Social Medicine and Health System Research, Hannover Medical School, Hannover, GermanyKlaus Rabe2Pneumology, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, GermanyHelgo Magnussen1Pulmonary Research Institute, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, GermanyHenrik Watz1Pulmonary Research Institute, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research, Grosshansdorf, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
